All articles by Clinical Trials Arena Team

Clinical Trials Arena Team

Pipeline Moves: Trial completion bumps advancement prospects for AstraZeneca’s oncology drug

The Clinical Trial Arena team also investigate other assets in oncology, Gaucher disease, bacterial infection, and diabetic eye and kidney disease.

Pipeline Moves: Amgen terminates Phase III osteogenesis imperfecta trial, approval prospects drop

The Clinical Trials Arena Team also reviews assets in oncology, psoriasis and developmental disorder.

Pipeline Moves: AbbVie and Janssen terminate Phase III lymphoma trial, approval prospects plummet

The Clinical Trials Arena team also reviews assets in central nervous system, gastrointestinal, oncology, respiratory diseases.

Pipeline Moves: Novartis completes ulcerative colitis trial, advancement prospects rise

The Clinical Trials Arena team also reviews assets in oncology, paediatric hormone deficiency, diabetic pain and ophthalmology.

Pipeline Moves: Novartis resumes Phase II myelofibrosis trial, oncology trial completions

The Clinical Trials Arena team also investigates the completion of Phase II trials in liver and pulmonary diseases, Phase I/II in paediatric and Phase Ib/IIa colorectal cancer trials.

Pipeline Moves: approval prospects jump for AstraZeneca’s breast cancer drug

The Clinical Trials Arena team also reviews assets in ophthalmology, multiple sclerosis, and multiple oncology indications.

Pipeline Moves: positive topline results in pulmonary hypertension, genetic and metabolic disorders

The Clinical Trials Arena team also investigates assets in chronic kidney disease, soft tissue sarcoma and haematological malignancies

Pipeline Moves: trial completions in glaucoma, lung, and oncology indications

The Clinical Trials Arena team also reviews a termination in severe swelling and topline results in cervical dystonia trials

Pipeline Moves: trial terminations in colorectal cancer, cardiovascular infections, and kidney injury

The Clinical Trials Arena team also reviews endpoint achievement in liver disease, and trial completions in metabolic syndrome and pouchitis.

Pipeline Moves: Trial completions in Duchenne muscular dystrophy and chronic urticaria

The Clinical Trials Arena team also investigates missed endpoints in wound infections, and terminations in head and neck cancer and liver cancer.